Canada

Pivot Pharmaceuticals Inc. (formerly Neurokine Pharmaceuticals Inc.)

Track

Track

No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
2.7
Doroudian, Ahmad Director of Issuer, Senior Officer of Issuer Executive Director
Transaction date
Purchase
Price
241.81
Quantity 16,560
Value CA$1,057,401
2.7
Doroudian, Ahmad Director of Issuer, Senior Officer of Issuer Executive Director
Transaction date
Purchase
Price
265.02
Quantity 65,514
Value CA$736,438
2.7
Doroudian, Ahmad Director of Issuer, Senior Officer of Issuer Executive Director
Transaction date
Purchase
Price
427.49
Quantity 99,469 +5.4%
Value US$4,464,150
2.7
Doroudian, Ahmad Director of Issuer, Senior Officer of Issuer Executive Director
Transaction date
Purchase
Price
1.62
Quantity 11,300 +4.8%
Value CA$18,283
2.7
Doroudian, Ahmad Director of Issuer, Senior Officer of Issuer Executive Director
Transaction date
Purchase
Price
1.74
Quantity 2,500 +0.0%
Value CA$4,340
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2018-05-21 2018-05-15 B Purchase
2.7
Doroudian, Ahmad

Director of Issuer, Senior Officer of Issuer

Executive Director
16,560
241.81
CA$1,057,401 		16,560 241.81 CA$1,057,401
2018-04-05 2018-04-02 B Purchase
2.7
Doroudian, Ahmad

Director of Issuer, Senior Officer of Issuer

Executive Director
65,514
265.02
CA$736,438 		65,514 265.02 CA$736,438
2023-11-17 2018-03-29 B Purchase
2.7
Doroudian, Ahmad

Director of Issuer, Senior Officer of Issuer

Executive Director
99,469 +5.4%
427.49
US$4,464,150 		99,469 +5.4% 427.49 US$4,464,150
2023-11-17 2018-02-26 B Purchase
2.7
Doroudian, Ahmad

Director of Issuer, Senior Officer of Issuer

Executive Director
11,300 +4.8%
1.62
CA$18,283 		11,300 +4.8% 1.62 CA$18,283
2023-11-16 2018-02-26 B Purchase
2.7
Doroudian, Ahmad

Director of Issuer, Senior Officer of Issuer

Executive Director
2,500 +0.0%
1.74
CA$4,340 		2,500 +0.0% 1.74 CA$4,340
Explore more

More insider trading research around Pivot Pharmaceuticals Inc. (formerly Neurokine Pharmaceuticals Inc.)

More insider trades in Canada
Insider trading in North America